Zhou C - Search Results

1

Obesity and altered angiogenic-related gene expression in endometrial cancer.

Cobb LP, Siamakpour-Reihani S, Zhang D, Qin X, Owzar K, Zhou C, Conrads TP, Maxwell GL, Darcy KM, Bateman NW, Litzi T, Bae-Jump V, Secord AA. Cobb LP, et al. Among authors: zhou c. Gynecol Oncol. 2021 Nov;163(2):320-326. doi: 10.1016/j.ygyno.2021.08.010. Epub 2021 Sep 15. Gynecol Oncol. 2021. PMID: 34538531 Free PMC article.

2

Rapamycin inhibits hTERT telomerase mRNA expression, independent of cell cycle arrest.

Bae-Jump VL, Zhou C, Gehrig PA, Whang YE, Boggess JF. Bae-Jump VL, et al. Among authors: zhou c. Gynecol Oncol. 2006 Mar;100(3):487-94. doi: 10.1016/j.ygyno.2005.08.053. Epub 2005 Oct 24. Gynecol Oncol. 2006. PMID: 16249016

3

The PTEN tumor suppressor inhibits telomerase activity in endometrial cancer cells by decreasing hTERT mRNA levels.

Zhou C, Bae-Jump VL, Whang YE, Gehrig PA, Boggess JF. Zhou C, et al. Gynecol Oncol. 2006 May;101(2):305-10. doi: 10.1016/j.ygyno.2005.10.038. Epub 2005 Dec 27. Gynecol Oncol. 2006. PMID: 16380156

4

Estrogen-receptor-dependent regulation of telomerase activity in human endometrial cancer cell lines.

Boggess JF, Zhou C, Bae-Jump VL, Gehrig PA, Whang YE. Boggess JF, et al. Among authors: zhou c. Gynecol Oncol. 2006 Nov;103(2):417-24. doi: 10.1016/j.ygyno.2006.03.032. Epub 2006 May 11. Gynecol Oncol. 2006. PMID: 16690106

5

Induction of apoptosis and inhibition of telomerase activity by arsenic trioxide (As2O3) in endometrial carcinoma cells.

Zhou C, Boggess JF, Bae-Jump V, Gehrig PA. Zhou C, et al. Gynecol Oncol. 2007 Apr;105(1):218-22. doi: 10.1016/j.ygyno.2006.11.027. Epub 2007 Feb 2. Gynecol Oncol. 2007. PMID: 17275888

6

Arsenic trioxide (As2O3) inhibits expression of estrogen receptor-alpha through regulation of the mitogen-activated protein kinase (MAPK) pathway in endometrial cancer cells.

Bae-Jump VL, Zhou C, Boggess JF, Gehrig PA. Bae-Jump VL, et al. Among authors: zhou c. Reprod Sci. 2008 Dec;15(10):1011-7. doi: 10.1177/1933719108324134. Reprod Sci. 2008. PMID: 19088370

7

Synergistic effect of rapamycin and cisplatin in endometrial cancer cells.

Bae-Jump VL, Zhou C, Boggess JF, Gehrig PA. Bae-Jump VL, et al. Among authors: zhou c. Cancer. 2009 Sep 1;115(17):3887-96. doi: 10.1002/cncr.24431. Cancer. 2009. PMID: 19484784 Free article.

8

Rapamycin potentiates the effects of paclitaxel in endometrial cancer cells through inhibition of cell proliferation and induction of apoptosis.

Shafer A, Zhou C, Gehrig PA, Boggess JF, Bae-Jump VL. Shafer A, et al. Among authors: zhou c. Int J Cancer. 2010 Mar 1;126(5):1144-54. doi: 10.1002/ijc.24837. Int J Cancer. 2010. PMID: 19688827 Free PMC article.

9

Metformin is a potent inhibitor of endometrial cancer cell proliferation--implications for a novel treatment strategy.

Cantrell LA, Zhou C, Mendivil A, Malloy KM, Gehrig PA, Bae-Jump VL. Cantrell LA, et al. Among authors: zhou c. Gynecol Oncol. 2010 Jan;116(1):92-8. doi: 10.1016/j.ygyno.2009.09.024. Epub 2009 Oct 12. Gynecol Oncol. 2010. PMID: 19822355 Free PMC article.

10

Rapamycin inhibits cell proliferation in type I and type II endometrial carcinomas: a search for biomarkers of sensitivity to treatment.

Bae-Jump VL, Zhou C, Boggess JF, Whang YE, Barroilhet L, Gehrig PA. Bae-Jump VL, et al. Among authors: zhou c. Gynecol Oncol. 2010 Dec;119(3):579-85. doi: 10.1016/j.ygyno.2010.08.025. Epub 2010 Sep 21. Gynecol Oncol. 2010. PMID: 20863555 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

21,164 results

Search Page

Filters